دورية أكاديمية

Obesity Takes Its Toll on Visceral Pain: High-Fat Diet Induces Toll-Like Receptor 4-Dependent Visceral Hypersensitivity.

التفاصيل البيبلوغرافية
العنوان: Obesity Takes Its Toll on Visceral Pain: High-Fat Diet Induces Toll-Like Receptor 4-Dependent Visceral Hypersensitivity.
المؤلفون: Tramullas M; APC Microbiome Institute, University College Cork, Cork, Ireland., Finger BC; School of Pharmacy, University College Cork, Cork, Ireland., Dinan TG; APC Microbiome Institute, University College Cork, Cork, Ireland.; Department of Psychiatry & Neurobehavioural Science, University College Cork, Cork, Ireland., Cryan JF; APC Microbiome Institute, University College Cork, Cork, Ireland.; Department of Anatomy & Neuroscience, University College Cork, Cork, Ireland.
المصدر: PloS one [PLoS One] 2016 May 09; Vol. 11 (5), pp. e0155367. Date of Electronic Publication: 2016 May 09 (Print Publication: 2016).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: Diet, High-Fat*, Obesity/*physiopathology , Toll-Like Receptor 4/*physiology , Visceral Pain/*physiopathology, Animals ; Brain/physiopathology ; Male ; Mice ; Mice, Inbred C57BL
مستخلص: Exposure to high-fat diet induces both, peripheral and central alterations in TLR4 expression. Moreover, functional TLR4 is required for the development of high-fat diet-induced obesity. Recently, central alterations in TLR4 expression have been associated with the modulation of visceral pain. However, it remains unknown whether there is a functional interaction between the role of TLR4 in diet-induced obesity and in visceral pain. In the present study we investigated the impact of long-term exposure to high-fat diet on visceral pain perception and on the levels of TLR4 and Cd11b (a microglial cell marker) protein expression in the prefrontal cortex (PFC) and hippocampus. Peripheral alterations in TLR4 were assessed following the stimulation of spleenocytes with the TLR4-agonist LPS. Finally, we evaluated the effect of blocking TLR4 on visceral nociception, by administering TAK-242, a selective TLR4-antagonist. Our results demonstrated that exposure to high-fat diet induced visceral hypersensitivity. In parallel, enhanced TLR4 expression and microglia activation were found in brain areas related to visceral pain, the PFC and the hippocampus. Likewise, peripheral TLR4 activity was increased following long-term exposure to high-fat diet, resulting in an increased level of pro-inflammatory cytokines. Finally, TLR4 blockage counteracted the hyperalgesic phenotype present in mice fed on high-fat diet. Our data reveal a role for TLR4 in visceral pain modulation in a model of diet-induced obesity, and point to TLR4 as a potential therapeutic target for the development of drugs to treat visceral hypersensitivity present in pathologies associated to fat diet consumption.
References: J Biol Chem. 2002 Apr 26;277(17):15028-34. (PMID: 11836257)
Psychoneuroendocrinology. 2012 Jun;37(6):729-41. (PMID: 21783325)
J Neurosci. 2009 Jan 14;29(2):359-70. (PMID: 19144836)
PLoS One. 2012;7(10):e47713. (PMID: 23091640)
Gut. 2006 Feb;55(2):182-90. (PMID: 16105890)
J Neurosci. 2010 Jan 27;30(4):1502-11. (PMID: 20107078)
PLoS One. 2014;9(2):e88904. (PMID: 24520424)
Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5856-61. (PMID: 15809417)
PLoS One. 2010;5(8):e12191. (PMID: 20808947)
Glia. 2008 Sep;56(12):1312-9. (PMID: 18615568)
Gastroenterology. 2006 Dec;131(6):1925-42. (PMID: 17188960)
J Biol Chem. 2001 May 18;276(20):16683-9. (PMID: 11278967)
Diabetes. 2011 Jun;60(6):1743-51. (PMID: 21515848)
Diabetes. 2007 Oct;56(10):2598-608. (PMID: 17626889)
Aliment Pharmacol Ther. 2012 Feb;35(4):403-13. (PMID: 22225517)
Neurogastroenterol Motil. 2010 Sep;22(9):1029-35, e268. (PMID: 20518856)
Obesity (Silver Spring). 2008 Jun;16(6):1248-55. (PMID: 18421279)
Neuroimmunomodulation. 2012;19(6):367-76. (PMID: 23051934)
J Clin Invest. 2006 Nov;116(11):3015-25. (PMID: 17053832)
Int J Clin Exp Med. 2015 Jul 15;8(7):11202-7. (PMID: 26379924)
Curr Protoc Neurosci. 2012;Chapter 9:Unit 9.40. (PMID: 23093353)
J Ren Nutr. 2010 Mar;20(2):112-20. (PMID: 19616452)
Ann Nutr Metab. 2013;63 Suppl 2:28-40. (PMID: 24217034)
Brain Behav Immun. 2015 Oct;49:255-66. (PMID: 26065826)
Mol Pharmacol. 2011 Jan;79(1):34-41. (PMID: 20881006)
Prog Mol Biol Transl Sci. 2015;131:1-30. (PMID: 25744668)
Ann N Y Acad Sci. 2011 Dec;1243:E1-39. (PMID: 22417140)
Eur J Neurosci. 2004 Jul;20(2):467-73. (PMID: 15233755)
Nature. 2006 Dec 14;444(7121):860-7. (PMID: 17167474)
Exp Neurol. 2012 Apr;234(2):262-70. (PMID: 22226600)
Am J Clin Nutr. 2006 Feb;83(2):461S-465S. (PMID: 16470013)
Int J Med Sci. 2010;7(5):251-9. (PMID: 20714435)
Diabetes. 2007 Aug;56(8):1986-98. (PMID: 17519423)
Neuroscience. 2010 Feb 3;165(3):675-83. (PMID: 19765638)
PLoS One. 2013;8(5):e65061. (PMID: 23741455)
Neurogastroenterol Motil. 2010 May;22(5):499-511. (PMID: 20236247)
Science. 2010 Nov 5;330(6005):783-8. (PMID: 21051630)
Diabetes. 2008 Jun;57(6):1470-81. (PMID: 18305141)
Gastroenterology. 2009 Apr;136(4):1339-48, e1-2. (PMID: 19249394)
Diabetes. 2009 Oct;58(10):2376-85. (PMID: 19592619)
Behav Brain Res. 2013 Sep 15;253:310-7. (PMID: 23872358)
Gastroenterology. 2012 Jan;142(1):165-173.e2. (PMID: 21963786)
Am J Physiol Gastrointest Liver Physiol. 2010 Aug;299(2):G440-8. (PMID: 20508158)
J Clin Gastroenterol. 2008 Jul;42 Suppl 2:S85-90. (PMID: 18542036)
J Nutr. 2014 Dec;144(12):1956-62. (PMID: 25320181)
Mediators Inflamm. 2015;2015:523896. (PMID: 26556957)
Stress. 2012 May;15(3):281-92. (PMID: 21992065)
Biol Psychiatry. 2014 Aug 15;76(4):340-8. (PMID: 24331544)
Gastroenterology. 2010 Jun;138(7):2418-25. (PMID: 20226190)
Pain. 2005 Aug;116(3):220-6. (PMID: 15936885)
Sci Rep. 2015;5:12549. (PMID: 26224622)
Gastroenterology. 1991 Feb;100(2):465-70. (PMID: 1985043)
J Pain. 2006 Feb;7(2):108-18. (PMID: 16459276)
Pain. 1990 Dec;43(3):377-86. (PMID: 2293146)
Annu Rev Med. 2011;62:361-80. (PMID: 21226616)
Metab Syndr Relat Disord. 2015 Dec;13(10):423-44. (PMID: 26569333)
Gut. 2010 Dec;59(12):1635-42. (PMID: 20926643)
Nat Protoc. 2007;2(10):2624-31. (PMID: 17948005)
Brain. 2003 May;126(Pt 5):1079-91. (PMID: 12690048)
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8514-9. (PMID: 12824464)
Exp Neurol. 2012 Apr;234(2):316-29. (PMID: 22001158)
Arch Immunol Ther Exp (Warsz). 2013 Apr;61(2):119-25. (PMID: 23307037)
J Neurosci. 2011 Oct 26;31(43):15450-4. (PMID: 22031891)
Eur J Neurosci. 2008 Jul;28(1):20-9. (PMID: 18662331)
Pain. 2013 Dec;154(12):2658-67. (PMID: 23932909)
Diabetes. 2007 Jul;56(7):1761-72. (PMID: 17456850)
Brain Behav Immun. 2014 Jan;35:33-42. (PMID: 23831150)
Pain Physician. 2015 Jul-Aug;18(4):E615-28. (PMID: 26218952)
Pain Pract. 2010 May-Jun;10(3):167-84. (PMID: 20384965)
Pain. 2009 Sep;145(1-2):120-8. (PMID: 19560270)
PLoS One. 2013;8(6):e65790. (PMID: 23762426)
Exp Diabetes Res. 2011;2011:848307. (PMID: 22144990)
Neuroscience. 2011 Sep 29;192:351-60. (PMID: 21742017)
المشرفين على المادة: 0 (Toll-Like Receptor 4)
تواريخ الأحداث: Date Created: 20160510 Date Completed: 20170726 Latest Revision: 20190219
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC4861320
DOI: 10.1371/journal.pone.0155367
PMID: 27159520
قاعدة البيانات: MEDLINE
الوصف
تدمد:1932-6203
DOI:10.1371/journal.pone.0155367